B型肝炎ワクチンの世界及び中国市場

• 英文タイトル：Global and China Hepatitis B Vaccines Market Insights, Forecast to 2027

• レポートコード：QY2108PAL8845
• 出版社/出版日：QYResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、135ページ
• 納品方法：Eメール（納期：1日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の当調査資料ではグローバルにおけるB型肝炎ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、B型肝炎ワクチンの種類別市場規模（酵母由来、CHO由来）、用途別市場規模（子供、大人）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。
・調査の概要
・調査のサマリー
・世界のB型肝炎ワクチン市場動向
・グローバル主要プレイヤーの競争状況・市場シェア
・世界におけるB型肝炎ワクチンの種類別市場規模（2016年-2027年）：酵母由来、CHO由来
・世界におけるB型肝炎ワクチンの用途別市場規模（2016年-2027年）：子供、大人
・B型肝炎ワクチンの中国市場分析
- B型肝炎ワクチンの中国市場規模（2016年-2027年）
- 中国におけるB型肝炎ワクチンの主要プレイヤー別市場シェア
- 中国におけるB型肝炎ワクチンの種類別市場規模：酵母由来、CHO由来
- 中国におけるB型肝炎ワクチンの用途別市場規模：子供、大人
・B型肝炎ワクチンの北米市場（2016年-2027年）
・B型肝炎ワクチンのヨーロッパ市場（2016年-2027年）
・B型肝炎ワクチンのアジア太平洋市場（2016年-2027年）
・B型肝炎ワクチンの中南米市場（2016年-2027年）
・B型肝炎ワクチンの中東・アフリカ市場（2016年-2027年）
・主要プレイヤーの情報：GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute
・市場機会・課題・リスク要因分析
・バリューチェーン・販売チャネル分析
・...

Hepatitis B vaccine is a vaccine that prevents hepatitis B.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Market Analysis and Insights: Global and China Hepatitis B Vaccines Market
This report focuses on global and China Hepatitis B Vaccines market.
In 2020, the global Hepatitis B Vaccines market size was US$ 1004.9 million and it is expected to reach US$ 1137.2 million by the end of 2027, with a CAGR of 1.8% during 2021-2027. In China the Hepatitis B Vaccines market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Hepatitis B Vaccines Scope and Market Size
Hepatitis B Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Hepatitis B Vaccines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Yeast Derived
CHO Derived

Segment by Application
Children
Adult

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute

レポート目次

1 Study Coverage
1.1 Hepatitis B Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hepatitis B Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis B Vaccines Revenue 2016-2027
2.1.2 Global Hepatitis B Vaccines Sales 2016-2027
2.2 Global Hepatitis B Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hepatitis B Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Hepatitis B Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hepatitis B Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hepatitis B Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hepatitis B Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Hepatitis B Vaccines Revenue Forecast by Region (2022-2027)

3 Global Hepatitis B Vaccines Competitor Landscape by Players
3.1 Global Top Hepatitis B Vaccines Manufacturers by Sales
3.1.1 Global Hepatitis B Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hepatitis B Vaccines Manufacturers by Revenue
3.2.1 Key Hepatitis B Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hepatitis B Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Hepatitis B Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hepatitis B Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hepatitis B Vaccines Revenue in 2020
3.2.6 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hepatitis B Vaccines Price by Manufacturers
3.4 Global Hepatitis B Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis B Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis B Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Hepatitis B Vaccines Market Size by Type (2016-2021)
4.1.1 Global Hepatitis B Vaccines Sales by Type (2016-2021)
4.1.2 Global Hepatitis B Vaccines Revenue by Type (2016-2021)
4.1.3 Hepatitis B Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hepatitis B Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Hepatitis B Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatitis B Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Hepatitis B Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Hepatitis B Vaccines Market Size by Application (2016-2021)
5.1.1 Global Hepatitis B Vaccines Sales by Application (2016-2021)
5.1.2 Global Hepatitis B Vaccines Revenue by Application (2016-2021)
5.1.3 Hepatitis B Vaccines Price by Application (2016-2021)
5.2 Hepatitis B Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Hepatitis B Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatitis B Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatitis B Vaccines Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Hepatitis B Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Hepatitis B Vaccines Sales YoY Growth 2016-2027
6.1.2 China Hepatitis B Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Hepatitis B Vaccines Market Share in Global Market 2016-2027
6.2 China Hepatitis B Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Hepatitis B Vaccines Players by Sales (2016-2021)
6.2.2 China Top Hepatitis B Vaccines Players by Revenue (2016-2021)
6.3 China Hepatitis B Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Hepatitis B Vaccines Price by Type (2016-2021)
6.4 China Hepatitis B Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hepatitis B Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Hepatitis B Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Hepatitis B Vaccines Price Forecast by Type (2022-2027)
6.5 China Hepatitis B Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Hepatitis B Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Hepatitis B Vaccines Price by Application (2016-2021)
6.6 China Hepatitis B Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hepatitis B Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Hepatitis B Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Hepatitis B Vaccines Price Forecast by Application (2022-2027)

7 North America
7.1 North America Hepatitis B Vaccines Market Size YoY Growth 2016-2027
7.2 North America Hepatitis B Vaccines Market Facts & Figures by Country
7.2.1 North America Hepatitis B Vaccines Sales by Country (2016-2021)
7.2.2 North America Hepatitis B Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Hepatitis B Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Hepatitis B Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Hepatitis B Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Hepatitis B Vaccines Market Facts & Figures by Country
9.2.1 Europe Hepatitis B Vaccines Sales by Country (2016-2021)
9.2.2 Europe Hepatitis B Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Hepatitis B Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Hepatitis B Vaccines Market Facts & Figures by Country
10.2.1 Latin America Hepatitis B Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Hepatitis B Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Hepatitis B Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Hepatitis B Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 NCPC
12.2.1 NCPC Corporation Information
12.2.2 NCPC Description and Business Overview
12.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NCPC Hepatitis B Vaccines Products Offered
12.2.5 NCPC Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Hepatitis B Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Bio Kangtai
12.4.1 Bio Kangtai Corporation Information
12.4.2 Bio Kangtai Description and Business Overview
12.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bio Kangtai Hepatitis B Vaccines Products Offered
12.4.5 Bio Kangtai Recent Development
12.5 Dynavax
12.5.1 Dynavax Corporation Information
12.5.2 Dynavax Description and Business Overview
12.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dynavax Hepatitis B Vaccines Products Offered
12.5.5 Dynavax Recent Development
12.6 Hissen
12.6.1 Hissen Corporation Information
12.6.2 Hissen Description and Business Overview
12.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hissen Hepatitis B Vaccines Products Offered
12.6.5 Hissen Recent Development
12.7 KM Biologics
12.7.1 KM Biologics Corporation Information
12.7.2 KM Biologics Description and Business Overview
12.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KM Biologics Hepatitis B Vaccines Products Offered
12.7.5 KM Biologics Recent Development
12.8 LG Life Sciences
12.8.1 LG Life Sciences Corporation Information
12.8.2 LG Life Sciences Description and Business Overview
12.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 LG Life Sciences Hepatitis B Vaccines Products Offered
12.8.5 LG Life Sciences Recent Development
12.9 Serum Institute
12.9.1 Serum Institute Corporation Information
12.9.2 Serum Institute Description and Business Overview
12.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Serum Institute Hepatitis B Vaccines Products Offered
12.9.5 Serum Institute Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Hepatitis B Vaccines Products Offered
12.11.5 GSK Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hepatitis B Vaccines Industry Trends
13.2 Hepatitis B Vaccines Market Drivers
13.3 Hepatitis B Vaccines Market Challenges
13.4 Hepatitis B Vaccines Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis B Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Yeast Derived
Table 3. Major Manufacturers of CHO Derived
Table 4. Global Hepatitis B Vaccines Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 5. Global Hepatitis B Vaccines Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hepatitis B Vaccines Sales by Regions (2016-2021) & (M Doses)
Table 7. Global Hepatitis B Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Hepatitis B Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hepatitis B Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 10. Global Hepatitis B Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hepatitis B Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hepatitis B Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hepatitis B Vaccines Sales by Manufacturers (2016-2021) (M Doses)
Table 14. Global Hepatitis B Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hepatitis B Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hepatitis B Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hepatitis B Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2020)
Table 20. Key Manufacturers Hepatitis B Vaccines Price (2016-2021) (USD/Doses)
Table 21. Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis B Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Hepatitis B Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis B Vaccines Sales by Type (2016-2021) (M Doses)
Table 26. Global Hepatitis B Vaccines Sales Share by Type (2016-2021)
Table 27. Global Hepatitis B Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hepatitis B Vaccines Revenue Share by Type (2016-2021)
Table 29. Hepatitis B Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Doses)
Table 30. Global Hepatitis B Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 31. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hepatitis B Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hepatitis B Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Doses)
Table 35. Global Hepatitis B Vaccines Sales by Application (2016-2021) (M Doses)
Table 36. Global Hepatitis B Vaccines Sales Share by Application (2016-2021)
Table 37. Global Hepatitis B Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hepatitis B Vaccines Revenue Share by Application (2016-2021)
Table 39. Hepatitis B Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Doses)
Table 40. Global Hepatitis B Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 41. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hepatitis B Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hepatitis B Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Doses)
Table 45. China Hepatitis B Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 46. China Hepatitis B Vaccines Sales Share by Company (2016-2021)
Table 47. China Hepatitis B Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. China Hepatitis B Vaccines Revenue Share by Company (2016-2021)
Table 49. China Hepatitis B Vaccines Sales (M Doses) by Type (2016-2021)
Table 50. China Hepatitis B Vaccines Sales Share by Type (2016-2021)
Table 51. China Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Hepatitis B Vaccines Price (USD/Doses) by Type (2016-2021)
Table 53. China Hepatitis B Vaccines Sales (M Doses) by Type (2022-2027)
Table 54. China Hepatitis B Vaccines Sales Share by Type (2022-2027)
Table 55. China Hepatitis B Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Hepatitis B Vaccines Revenue Share by Type (2022-2027)
Table 57. China Hepatitis B Vaccines Price (USD/Doses) by Type (2022-2027)
Table 58. China Hepatitis B Vaccines Sales (M Doses) by Application (2016-2021)
Table 59. China Hepatitis B Vaccines Sales Share by Application (2016-2021)
Table 60. China Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Hepatitis B Vaccines Price (USD/Doses) by Application (2016-2021)
Table 62. China Hepatitis B Vaccines Sales (M Doses) by Application (2022-2027)
Table 63. China Hepatitis B Vaccines Sales Share by Application (2022-2027)
Table 64. China Hepatitis B Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Hepatitis B Vaccines Revenue Share by Application (2022-2027)
Table 66. China Hepatitis B Vaccines Price (USD/Doses) by Application (2022-2027)
Table 67. North America Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 68. North America Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hepatitis B Vaccines Sales by Region (2016-2021) & (M Doses)
Table 72. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hepatitis B Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 76. Europe Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 80. Latin America Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 84. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 90. GSK Hepatitis B Vaccines Product
Table 91. GSK Recent Development
Table 92. NCPC Corporation Information
Table 93. NCPC Description and Business Overview
Table 94. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 95. NCPC Product
Table 96. NCPC Recent Development
Table 97. Merck Corporation Information
Table 98. Merck Description and Business Overview
Table 99. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 100. Merck Product
Table 101. Merck Recent Development
Table 102. Bio Kangtai Corporation Information
Table 103. Bio Kangtai Description and Business Overview
Table 104. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 105. Bio Kangtai Product
Table 106. Bio Kangtai Recent Development
Table 107. Dynavax Corporation Information
Table 108. Dynavax Description and Business Overview
Table 109. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 110. Dynavax Product
Table 111. Dynavax Recent Development
Table 112. Hissen Corporation Information
Table 113. Hissen Description and Business Overview
Table 114. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 115. Hissen Product
Table 116. Hissen Recent Development
Table 117. KM Biologics Corporation Information
Table 118. KM Biologics Description and Business Overview
Table 119. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 120. KM Biologics Product
Table 121. KM Biologics Recent Development
Table 122. LG Life Sciences Corporation Information
Table 123. LG Life Sciences Description and Business Overview
Table 124. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 125. LG Life Sciences Product
Table 126. LG Life Sciences Recent Development
Table 127. Serum Institute Corporation Information
Table 128. Serum Institute Description and Business Overview
Table 129. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 130. Serum Institute Product
Table 131. Serum Institute Recent Development
Table 132. Hepatitis B Vaccines Market Trends
Table 133. Hepatitis B Vaccines Market Drivers
Table 134. Hepatitis B Vaccines Market Challenges
Table 135. Hepatitis B Vaccines Market Restraints
Table 136. Hepatitis B Vaccines Customers List
Table 137. Hepatitis B Vaccines Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Global Hepatitis B Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Yeast Derived Product Picture
Figure 4. CHO Derived Product Picture
Figure 5. Global Hepatitis B Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adult
Figure 8. Hepatitis B Vaccines Report Years Considered
Figure 9. Global Hepatitis B Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hepatitis B Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Hepatitis B Vaccines Sales 2016-2027 (M Doses)
Figure 12. Global Hepatitis B Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Figure 14. Global Hepatitis B Vaccines Sales Market Share by Region in 2020
Figure 15. Global Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)
Figure 16. Global Hepatitis B Vaccines Revenue Market Share by Region in 2020
Figure 17. Global Hepatitis B Vaccines Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2020
Figure 19. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Figure 21. Global Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 22. Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)
Figure 23. Global Hepatitis B Vaccines Revenue Market Share by Type in 2020
Figure 24. Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Figure 25. Global Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 26. Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2021)
Figure 27. Global Hepatitis B Vaccines Revenue Market Share by Application in 2020
Figure 28. China Hepatitis B Vaccines Sales Growth Rate 2016-2027 (M Doses)
Figure 29. China Hepatitis B Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Hepatitis B Vaccines Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Hepatitis B Vaccines Players Market Share by Revenue in Hepatitis B Vaccines in 2020
Figure 32. China Hepatitis B Vaccines Revenue Share by Type (2016-2021)
Figure 33. China Hepatitis B Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Hepatitis B Vaccines Revenue Share by Application (2016-2021)
Figure 35. China Hepatitis B Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Hepatitis B Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 37. North America Hepatitis B Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Hepatitis B Vaccines Sales Market Share by Country in 2020
Figure 39. North America Hepatitis B Vaccines Revenue Market Share by Country in 2020
Figure 40. U.S. Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 41. U.S. Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 43. Canada Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Hepatitis B Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 45. Europe Hepatitis B Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Hepatitis B Vaccines Sales Market Share by Country in 2020
Figure 47. Europe Hepatitis B Vaccines Revenue Market Share by Country in 2020
Figure 48. Germany Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 49. Germany Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 51. France Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 53. U.K. Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 55. Italy Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 57. Russia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Hepatitis B Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 59. Asia Pacific Hepatitis B Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region in 2020
Figure 61. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region in 2020
Figure 62. China Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 63. China Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 65. Japan Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 67. South Korea Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 69. India Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 71. Australia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 73. Taiwan Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 75. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 77. Thailand Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 79. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 81. Philippines Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 83. Vietnam Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Hepatitis B Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 85. Latin America Hepatitis B Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Hepatitis B Vaccines Sales Market Share by Country in 2020
Figure 87. Latin America Hepatitis B Vaccines Revenue Market Share by Country in 2020
Figure 88. Mexico Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 89. Mexico Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 91. Brazil Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 93. Argentina Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Hepatitis B Vaccines Sales Growth Rate 2016-2021 (M Doses)
Figure 95. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country in 2020
Figure 98. Turkey Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 99. Turkey Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 101. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Hepatitis B Vaccines Sales Growth Rate (2016-2021) (M Doses)
Figure 103. UAE Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Hepatitis B Vaccines Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed

以下、関連資料のご紹介

経口ワクチンの世界及び中国市場

Global and China Oral Vaccines Market Insights, Forecast to 2027
QY2108PAL8903 2021年6月 150Pages
QYResearch社発行の当調査資料ではグローバルにおける経口ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、経口ワクチンの種類別市場規模（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン）、用途別市場規模（公共用、個人...

口蹄疫（FMD）ワクチンの世界及び中国市場

Global and China Foot and Mouth Disease (FMD) Vaccines Market Insights, Forecast to 2027
QY2108PAL8829 2021年7月 162Pages
QYResearch社発行の当調査資料ではグローバルにおける口蹄疫（FMD）ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、口蹄疫（FMD）ワクチンの種類別市場規模（緊急ワクチン、従来型ワクチン）、用途別市場規模（牛、豚、羊、山羊...

世界の経口投与ワクチン市場インサイト・予測（～2027年）

Global Vaccines Administered Orally Market Insights and Forecast to 2027
QY2108PAL4049 2021年8月 126Pages
本調査資料は経口投与ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。経口投与ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ヒト用、動物用）、用途別市場規模（公共用、個人用）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中...

C型肝炎ウイルスエンベロープタンパク質E2の世界市場 2020年

Global Hepatitis C Virus Envelope Protein E2 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201111773 2020年10月20日 105Pages
本書では、C型肝炎ウイルスエンベロープタンパク質E2の世界市場を調査対象にし、C型肝炎ウイルスエンベロープタンパク質E2の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（E-20、MBL-...

渡航者用ワクチンの世界市場 2020年

Global Travelers Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201109873 2020年10月20日 107Pages
本書では、渡航者用ワクチンの世界市場を調査対象にし、渡航者用ワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱ワクチン、肝炎ワクチン、コレラ...

虚血性肝炎治療の世界市場 2020年

Global Ischemic Hepatitis Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
GIR201115728 2020年10月 100Pages
本書では、虚血性肝炎治療の世界市場を調査対象にし、虚血性肝炎治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（外科的治療、薬物治療）、用途別分析（病院、クリニック、外来手術センター）、市場予測（202...

肝炎診断テストの世界市場 2020年

Global Hepatitis Diagnostics Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025
GIR201115569 2020年10月 100Pages
本書では、肝炎診断テストの世界市場を調査対象にし、肝炎診断テストの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血液検査、画像検査、肝生検）、用途別分析（病院、診療所、研究機関）、市場予測（2021年～...

肝炎ウイルス診断テストの世界市場 2020年

Global Hepatitis Viruses Diagnostic Tests Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201111774 2020年10月20日 109Pages
本書では、肝炎ウイルス診断テストの世界市場を調査対象にし、肝炎ウイルス診断テストの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（酵素免疫測定法（EIA）、組換え免疫ブロット法（RIBA）...

B型肝炎診断テストの世界市場 2020年

Global Hepatitis B Diagnostic Tests Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201111772 2020年10月20日 102Pages
本書では、B型肝炎診断テストの世界市場を調査対象にし、B型肝炎診断テストの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（酵素免疫測定キット、ポイントオブケア検査キット）、用途別分析（病院...

A型肝炎ウイルス細胞受容体2の世界市場 2020年

Global Hepatitis A Virus Cellular Receptor 2 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201111771 2020年10月20日 100Pages
本書では、A型肝炎ウイルス細胞受容体2の世界市場を調査対象にし、A型肝炎ウイルス細胞受容体2の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（IMM-1802、LY-3321367、MCL...

C型肝炎ウイルスエンベロープタンパク質E2の世界市場 2020年 Market Overview The global Hepatitis C Virus Envelope Protein E2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatit…
渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis Diagnostics Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis Diagnost…
虚血性肝炎治療の世界市場 2020年 Market Overview The global Ischemic Hepatitis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ischemic Hepatit…
B型肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis B Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis B Diag…